Correlating Electrically Evoked Compound Action Potential Thresholds with Cochlear Implant Position Using Validated Computed Tomography–Based Electrode Localization
The Journal of International Advanced Otology · 19.11.2026 · 22 (6) · 1-11
DOI: 10.65717/iao.2026.262557 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of International Advanced Otology, online erschienen am 19.11.2026. Verfasst von Fergio Sismono und 3 weiteren Autor:innen. Beteiligte Einrichtung: European Institute for ORL-HNS, ZAS Hospitals Antwerp, Wilrijk, Antwerp, Belgium. Hauptthemen laut MEDLINE: Cochlear Implants, Cochlear Implantation, Cone-Beam Computed Tomography, Action Potentials. Die Arbeit nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
BACKGROUND: Electrically evoked compound action potential thresholds (TECAP) are quick, accessible, and objective measurements used to evaluate the electrode-to-neuron interface in cochlear implant recipients. While TECAP levels are assumed to covary with electrode position, limited sensitivity of previous electrode localization methods has thus far complicated a detailed analysis of this relationship. This study utilized high-resolution cone-beam computed tomography (CT) and a validated algorithm in order to reevaluate the relationship between electrode position and threshold profiles.METHODS: Intra-operative TECAPs and CT scans from 16 adult recipients of Cochlear Nucleus Contour Advance arrays were retrospectively analyzed. Electrode-to-modiolar wall distances (EMDs), electrode-to-Rosenthal’s canal distances (ERDs) and mid-modiolar axis distances were determined and correlated with the threshold profiles.RESULTS: Linear regression analysis on a per subject basis confirmed that TECAP significantly increased with EMD and ERD. Electrode-toRosenthal’s canal distances yielded higher R2 values than EMD in 13 of 16 subjects and demonstrated near-perfect correlation in 3 individuals (R2 > 0.8, P < .001). Substantial inter-subject variability was also observed in regression slopes and intercepts, which may partly reflect subject-specific neural health. A linear mixed model accounting for this variability was fitted and explained 69.4% of the total variance (R2> 0.694, P < .001).CONCLUSION: The results from this study suggest that TECAP profiles are associated with mediolateral electrode position and are possibly affected by subject-specific differences in neural health. Incorporating electrode position from specialized CT analysis algorithms into neural health measures may help isolate the neural aspects and enable novel therapeutic applications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- European Institute for ORL-HNS, ZAS Hospitals Antwerp, Wilrijk, Antwerp, Belgium.
- Laboratory of Biomedical Physics, University of Antwerp, Antwerp, Belgium.
ORCID-Profile: Fergio Sismono, Marc Leblans, Joris Dirckx, Andrzej Zarowski
Zitieren
APA
Sismono, F., Leblans, M., Dirckx, J., & Zarowski, A. (2026). Correlating Electrically Evoked Compound Action Potential Thresholds with Cochlear Implant Position Using Validated Computed Tomography–Based Electrode Localization. The Journal of International Advanced Otology, 22(6), 1-11. https://doi.org/10.65717/iao.2026.262557
Vancouver
Sismono F, Leblans M, Dirckx J, Zarowski A. Correlating Electrically Evoked Compound Action Potential Thresholds with Cochlear Implant Position Using Validated Computed Tomography–Based Electrode Localization. The Journal of International Advanced Otology. 2026;22(6):1-11. doi:10.65717/iao.2026.262557
BibTeX
@article{Sismono2026,
author = {Sismono, Fergio and Leblans, Marc and Dirckx, Joris and Zarowski, Andrzej},
title = {Correlating Electrically Evoked Compound Action Potential Thresholds with Cochlear Implant Position Using Validated Computed Tomography–Based Electrode Localization},
journal = {The Journal of International Advanced Otology},
year = {2026},
volume = {22},
number = {6},
pages = {1--11},
doi = {10.65717/iao.2026.262557}
}
EUVIMED